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 Implication for health policy/practice/research/medical edu-
cation:
Occult hepatitis B infection is important entity in hemodi-
alysis patients and study of this article is recommended to 
the epidemiologists, hepatologists, virologists, nephrologists 
and other researchers who are interested in the field of public 
health.
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Occult hepatitis B (OHB) is not a new entity and there 
are many reports of patients with  hepatitis B virus (HBV) 
evidence replication in the absence of detectable hepati-
tis B surface antigen (HBsAg) and occasionally other HBV 
serologic markers (1). After introducing highly sensitive 
and specific tests for HBs Ag and HBV DNA, the diagno-
sis of OBH is easier and the importance of clinical entity 
of OBH is more controversial. In this issue of Hepatitis 
Monthly, Abu El Makarem reported the prevalence of oc-
cult hepatitis B virus infection in hemodialysis patients 
from Egypt with considering the hepatitis C Virus (HCV) 
Infection (2). Prevalence of HBV DNA detection in hemo-
dialysis patients was reported 4.1%, and the authors con-
cluded occult HBV infection (OBI) in those patients. They 
did not find any correlation between the variables and 
OBI. I would like to mention that finding the HBV DNA 
in the serum is not parallel to OBI and it is better to use 
the term of OHB instead of OBI in their cases. Moreover, 
in a literature review it has been suggested  that occult 
HBV in patients with chronic HCV infection has a possible 
correlation with higher grades of liver damage or even 
developing hepatocellular carcinoma (3). In addition, 
chronic HCV infection is frequently reported with occult 
HBV infection, due to almost the same route of transmis-
sion and risk factors (3). 
Egypt has the highest prevalence of HCV infection in 
the world (4). However the detection of OBH requires 
assays with the highest sensitivity and specificity and a 
lower limitation to detect less than 10 IU/ml HBV DNA 
(5). It is very interesting for us that the authors declared 
they used the real time PCR kit (COBAS Taqman HBV Test; 
cutoff detection: 6 IU/mL) that is a very sensitive test in 
their study. As they presented, the prevalence of anti-HBc 
Ab as well as the history of HBV infection in group one 
(HCV RNA positive ones) was more common than group 
two (HCV RNA negative). This condition is relatively more 
common in patients with HCV infection that seems to be 
related to influence on the replicative capacity and laten-
cy of HBV and the main risk factors for airing these infec-
tions.  The authors did not find any relation between the 
ALT level and the presence of HBV DNA in the serum, In 
my opinion the liver biopsy provides more relevant data 
than ALT in liver damage specifically in hemodialysis pa-
tients (6).
End-stage renal disease (ESRD) is a significant problem 
in almost all countries and the prevalence has increased 
considerably in developing countries especially in Middle 
East countries. The prevalence of HCV infection among 243 Hepat Mon. 2012;12(4)
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hemodialysis patients differs in different parts of Middle 
East countries which is 48% in Egypt (7). The prevalence 
of OBH in hemodialysis patients varies from 0% to more 
than 20% in different studies and it requires more investi-
gations with more sample size to find out OBH impact in 
transmission of HBV infection in hemodialysis centers.
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